Concepedia

Ying-Ka Ingar Lau

YI

Statistics

Publications

9

Citations

648

H-Index

9

Active since

1998

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Columbia University

Columbia University Irving Medical Center

Cancer Genetics (United States)

Ying-Ka Ingar Lau is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, oncology, and cancer cell signaling.

Publications per year

1998–2018

9

Publications

9

Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer

Qing‐Bai She, Sofia K. Gruvberger-Saal, Matthew Maurer et al. · BMC Cancer · 2016 · 195 citations · Full text

, , +17

Merlin Is a Potent Inhibitor of Glioma Growth

Ying-Ka Ingar Lau, Lucas B. Murray, Sean S. Houshmandi et al. · Cancer Research · 2008 · 107 citations · Full text

, , +15

Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study.

S.C. Srivastava, H.L. Atkins, Gerbail T. Krishnamurthy et al. · PubMed · 1998 · 92 citations

, , +17

Metformin and erlotinib synergize to inhibit basal breast cancer

Ying-Ka Ingar Lau, Xing Du, Vinayak Rayannavar et al. · Oncotarget · 2014 · 56 citations · Full text

, , +16

Survival factor NFIL3 restricts FOXO-induced gene expression in cancer

Megan Keniry, Maira M. Pires, Sarah M. Mense et al. · Genes & Development · 2013 · 55 citations · Full text

, , +17

1–5 of 9